• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MOLECULAR, INC. ABBOTT REALTIME IDH1 AMPLIFICATION REAGENT KIT; SOMATIC GENE MUTATION DETECTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MOLECULAR, INC. ABBOTT REALTIME IDH1 AMPLIFICATION REAGENT KIT; SOMATIC GENE MUTATION DETECTION SYSTEM Back to Search Results
Model Number 08N90-090
Device Problem Non Reproducible Results (4029)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/05/2019
Event Type  malfunction  
Manufacturer Narrative
Complaint investigation will be performed.
 
Event Description
Customer alleges discrepant results when running the realtime idh1 assay.Customer originally tested patient sample id dl-19-82019 on (b)(6) 2019 with result r132c detected (near the threshold cycle).Patient sample was reported as r132c.On (b)(6) 2019, customer tested sample patient extraction as part of internal validation and it generated a resulted of not detected (this time result for r132g was near the threshold cycle).Customer continued to test the sample as results were erratic.Four additional retests were performed, which resulted in 3 not detected results and one result of r132g detected.Customer confirmed that the reporting results are associated with patient management.Customer is running whole blood samples.Controls were within range; global service and support, research and development and technical product specialist have reviewed the log files.Per the customer, eluates were stored properly according the idh1 package insert.There has not been an allegation of adverse impact to patient management.The customer stated that he had a follow up conversation with the treating physician.The treating physician has both mutations (r132c and r132g) as part of the patient's record.The physician said that the treatment protocol does not change based on the patient having either only one or both mutations.The treating physician did confirm that two different sample types had been sent in for the original testing and the repeat testing.One sample type was bone marrow and the other sample type was blood.
 
Manufacturer Narrative
On january 22, 2020 lot number information was made available.Therefore, follow up report includes lot number, expiration date and manufacture date.Investigation into this complaint was completed february 14, 2020.Investigation included a customer data review, a quality data review, and a complaint history review.The results of the investigation are summarized as follows: customer data review: results logs attached to the complaint were reviewed.All runs were valid, met all assay specification requirements, and no error codes or flags were displayed for the controls.There is no indication that the abbott realtime idh1 amplification kit (list 08n90-90) lot 498208 is performing outside of established design performance specifications.Quality data review: device history record (dhr) review for abbott realtime idh1 amplification kit (list 08n90-90) lot 498208 and components was performed.The review did not identify any issues which could result in the reported complaint.The products passed quality specifications at the time of release.The capa review was performed for abbott realtime idh1 amplification kit (list 08n90-90) lot 498208 and components and did not identify any internal or post-production use issues related to these lot numbers.Complaint history review: the lot specific complaint history review for abbott realtime idh1 amplification kit (list 08n90-90) lot 498208 did not identify any additional complaints related to the reported issue.Based on the results of the investigation elements, a product deficiency for the abbott realtime idh1 amplification kit (list 08n90-90) lot 498208 was not identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABBOTT REALTIME IDH1 AMPLIFICATION REAGENT KIT
Type of Device
SOMATIC GENE MUTATION DETECTION SYSTEM
Manufacturer (Section D)
ABBOTT MOLECULAR, INC.
1300 e. touhy ave.
des plaines IL 60018 3315
MDR Report Key9613389
MDR Text Key191918319
Report Number3005248192-2020-00001
Device Sequence Number1
Product Code OWD
UDI-Device Identifier00884999047358
UDI-Public00884999047358
Combination Product (y/n)N
PMA/PMN Number
P170041
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 02/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this a Product Problem Report? Yes
Device Operator No Information
Device Expiration Date10/31/2020
Device Model Number08N90-090
Device Catalogue Number08N90-090
Device Lot Number498208
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 12/27/2019
Initial Date FDA Received01/21/2020
Supplement Dates Manufacturer Received01/22/2020
Supplement Dates FDA Received02/18/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-